Placental DNA methylation in caesarean sections - a pilot study.

Area of Science:

• Epigenetics
• Obstetrics
• Perinatal Health

Background:

• Caesarean section (CS) is a prevalent global medical procedure.
• CS is hypothesized to influence DNA methylation, potentially linking to infant immune-mediated diseases like diabetes.
• Understanding CS's impact on placental epigenetics is crucial for infant health outcomes.

Purpose of the Study:

• To investigate the association between caesarean section and placental DNA methylation patterns.
• To measure global DNA methylation in placental tissue across different delivery modes.

Main Methods:

• Study included 111 healthy pregnant women at term.
• Global DNA methylation was assessed using an ELISA-based kit in placental tissue.
• Compared methylation levels between vaginal delivery, elective CS (ECS), and intrapartum CS groups.

Main Results:

• Global DNA methylation was significantly lower in elective CS (3.02) compared to intrapartum CS (3.71) and vaginal deliveries (3.64).
• No significant difference in methylation was observed between intrapartum CS and vaginal deliveries.
• Placental DNA methylation showed sexual dimorphism in vaginal deliveries (males higher than females), but not in CS groups.

Conclusions:

• Caesarean sections performed without preceding uterine contractions significantly impact placental global DNA methylation.
• Sexual dimorphism in placental global DNA methylation was observed.
• Further research on specific gene methylation is warranted to understand CS effects and sexual dimorphism in newborns.